Company Snapshot: RXSD  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Rexall Sundown Announces Fourth Quarter Sales of $159 Million and EPS of $0.21

               Fiscal Year Record Revenue Exceeds $595 Million

    BOCA RATON, Fla., Sept. 29 /PRNewswire/ -- Rexall Sundown, Inc.
(Nasdaq: RXSD) announced  results for its fourth quarter and fiscal year ended
August 31, 1999.
     Net sales for the fourth quarter were $159.0 million, a 3.6% increase
over the $153.6 million recorded in the same period of the prior year.  Net
income was $13.6 million for the three months just ended, a decrease of 34%
compared to the $20.6 million in last year's fourth quarter.  Diluted earnings
per share for the fourth quarter of $0.21 decreased 25% from $0.28 in the
fourth quarter of last year.  The decline in earnings per share was mitigated
by the positive impact of the Company's repurchase of its shares.
    In making the announcement, Damon DeSantis, the Company's President and
Chief Executive Officer, stated, "Despite difficult comparisons against 1998,
we still experienced a sales increase in the fourth quarter."  Sales to
retailers rose 4% and sales of Rexall Showcase International, the Company's
direct sales division, increased slightly during the quarter.
    As a result of the costs related to the Company's ongoing commitment to
consumer advertising and product development, as well as the strengthening of
its overall infrastructure and expansion of the global operations of Rexall
Showcase, the Company experienced a decline in net income for the fourth
quarter.  Mr. DeSantis said, "We view our increased spending related to
branding and our ability to timely commercialize new products as long-term
investments which are necessary to maintain and enhance our leadership
position and strengthen our competitive advantage in the maturing nutritional
products industry."
    For the fiscal year ended August 31, 1999, net sales increased 12.2% to
$595.7 million from $530.7 million the previous year and net income of $60.1
million declined $9.2 million, or 13.2%, from the 1998 pro forma results of
$69.2 million.  The Company increased its consumer advertising by over $18
million during fiscal 1999, more than doubling the 1998 spending level.  The
Company was able to expand upon its leadership position in vitamins and
herbals, achieving record market share of 12.9% in the U.S. food, drug and
mass markets for the 52-week period ended August 22, 1999, an increase of 2
share points or 18% over 1998.  For the same period, the Company's growth at
retail outpaced that of all other participants in the nutritional category,
contributing 34% of the total dollar growth of the entire category.  Diluted
earnings per share for the 1999 fiscal year were $0.88, a decrease of 6.4%,
compared to $0.94 in 1998.
    Damon DeSantis added, "1999 was a year in which the entire nutritional
industry had to adjust from the rapid growth of 1997 and 1998.  Despite a slow
down in industry growth to single digits, we were able to achieve double-digit
top-line growth while we continued to invest for the future to ensure our
long-term dominance in the nutritional industry."  In total, the Company
invested over $27 million in 1999 to strengthen its infrastructure through the
installation of new manufacturing and packaging equipment, by expanding
capacity and increasing the capabilities of its laboratories, and completing
the installation of a new enterprise-wide computer system to support the
global expansion of Rexall Showcase International.   "These investments,
coupled with the planned retrofit of our manufacturing facility in fiscal
2000, will conclude a three-year program to broaden our global reach and
facilitate our future growth while we continue to deliver the highest quality
products, at the best value, to meet consumer needs," said Mr. DeSantis.
    In conclusion Mr. DeSantis stated, "We believe strongly in the long-term
growth prospects for the nutritional industry and our Company and that the
aging demographics and desire to achieve a better quality of life will
continue to fuel the dynamics of the industry well into the future."
    Rexall Sundown, Inc., develops, manufactures and distributes vitamins,
nutritional supplements and other consumer health products in the United
States and internationally.  Visit the Company's websites at
http://www.rexallsundown.com or http://www.rexallshowcase.com .

    This press release may contain "forward-looking statements" as such term
is defined in the Private Securities Litigation Reform Act of 1995 or by the
Securities and Exchange Commission in its rules, regulations and releases,
which represents the Company's interpretation or beliefs.  These forward-
looking statements, by their nature, involve substantial risks and
uncertainties, certain of which may be beyond the Company's control and actual
results may differ materially depending on a variety of important factors
including uncertainties related to acquisitions, government regulation,
managing and maintaining growth, the effect of adverse publicity, litigation,
reliance on independent distributors of Rexall Showcase, competition and other
factors described in the Company's filings with the Securities and Exchange
Commission.
                    REXALL SUNDOWN, INC. AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF OPERATIONS
                   (In thousands, except per share amounts)
                                 (Unaudited)
                                      Three Months Ended             %
                                            August 31,           Increase
                                       1999            1998    (Decrease)
    Net sales                      $159,008        $153,553          3.6%
    Cost of sales                    69,639          65,680          6.0%
                  Gross profit       89,369          87,873          1.7%
    Selling, general and
     administrative expenses         67,744          56,167         20.6%
                  Operating
                   income            21,625          31,706       (31.8%)
    Other income, net                   101           1,214       (91.7%)
    Income before income
     tax provision                   21,726          32,920       (34.0%)
    Income tax provision              8,124          12,297       (33.9%)

    Net income                      $13,602         $20,623       (34.0%)

    Pro forma net income (A)        $13,602         $20,623       (34.0%)

    Pro forma income per
     common share:
        Basic                        $ 0.21           $0.29
        Diluted                      $ 0.21           $0.28

    Weighted average common
     shares outstanding:

        Basic                        64,407          71,934
        Diluted                      65,462          74,229


                                      Twelve Months Ended            %
                                             August 31,           Increase
                                       1999            1998      (Decrease)
    Net sales                      $595,664        $530,741         12.2%
    Cost of sales                   258,777         223,231         15.9%
                   Gross profit     336,887         307,510          9.6%
    Selling, general
     and administrative expenses    243,550         201,655         20.8%
                   Operating
                    income           93,337         105,855         (11.8%)
    Other income, net                 2,438           4,399         (44.6%)
    Income before income
     tax provision                   95,775         110,254         (13.1%)
    Income tax provision             35,713          40,078         (10.9%)

    Net income                      $60,062         $70,176         (14.4%)

    Pro forma net income(A)         $60,062         $69,234         (13.2%)

    Pro forma income per
     common share:
        Basic                         $0.89           $0.97
        Diluted                       $0.88           $0.94

    Weighted average common
     shares outstanding:

        Basic                        67,212          71,196
        Diluted                      68,564          73,773

    (A) Pro forma net income reflects a pro forma tax provision for Richardson
        Labs, Inc. for periods prior to the January 1998 business combination
        as Richardson was an S corporation and not subject to corporate income
        taxes.
                         CONSOLIDATED BALANCE SHEETS
                                (In thousands)
                                 (Unaudited)

                                                August 31,        August 31,
                                                    1999               1998
    ASSETS
    Current assets:
       Cash and marketable securities              $2,124           $119,394
       Trade accounts receivable, net              71,332             60,805
       Inventory                                  114,861             77,727
       Other current assets                        23,469             11,630
    Total current assets                          211,786            269,556
    Property, plant and
     equipment, net                                69,274             56,697
    Other assets                                   14,291             13,105

    Total assets                                 $295,351           $339,358

    LIABILITIES AND SHAREHOLDERS'EQUITY
    Current liabilities:
       Accounts payable                           $24,381            $21,653
       Accrued expenses and
        other current liabilities                  24,280             27,260
       Short-term debt                             15,000                 --
         Total current liabilities                 63,661             48,913
    Other liabilities                                 722                384
    Shareholders' equity                          230,968            290,061

    Total liabilities and shareholders' equity   $295,351           $339,358


SOURCE Rexall Sundown




Back to Topback to top

Related links:
  • http://www.rexallshowcase.com
    CONTACT:
    Investors, Donna Conners, Director of
    Financial Planning, Press, Carol Walters, Manager Corporate
    Communications, both of Rexall Sundown, 561-241-9400; or General,
    Karen Griffiths, or Analysts, Vanessa Schwartz of the Financial
    Relations Board, 212-661-8030